2 sentences that change everything you THOUGHT you knew about trading

If you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfast... go to work... But if you say these two sentences to your broker... you could collect as much as $1,250 on Friday... no matter where you live, whether you're working or already retired. It all has to do with a unique stock market secret that's worked 97% of the time for the past 8 years running.

HRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.76%

Insider Buying (Last 12 Months): $260,650.00

Insider Selling (Last 12 Months): $0.00

Heron Therapeutics Insider Trading History Chart

Heron Therapeutics Share Price & Price History

^$1.78

+0.30 (1.20%)

As of 11/4/2024 01:00 AM ET

Days: 30 | 90 | 365

The Crypto That’s Making Wall Street Sweat

From Crypto 101 Media | Ad

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

Heron Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/16/2023	Craig A Collard	CEO	Buy	150,000	$0.92	$138,000.00	186,496
11/16/2023	Ira Duarte	CFO	Buy	85,000	$0.89	$75,650.00	85,000
11/16/2023	William P Forbes	EVP	Buy	50,000	$0.94	$47,000.00	54,000
7/21/2023	Adam Morgan	Director	Buy	2,486,744	$1.37	$3,406,839.28	6,986,744
5/3/2022	Kimberly Manhard	EVP	Sell	1,504	$4.76	$7,159.04	10,872
12/21/2021	Christian Waage	Director	Sell	300	$9.73	$2,919.00

The Crypto That’s Making Wall Street Sweat

From Crypto 101 Media | Ad

The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.

Click here to discover our #1 crypto for the market right now – poised for massive growth

SEC Filings (Institutional Ownership Changes) for Heron Therapeutics (NASDAQ:HRTX)

80.01% of Heron Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Heron Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/4/2024	Los Angeles Capital Management LLC	220,834	$0.44M	0.0%	-7.6%	0.146%
10/31/2024	Principal Financial Group Inc.	102,651	$0.20M	0.0%	+456.5%	0.068%
10/25/2024	Cutter & CO Brokerage Inc.	19,535	$39K	0.0%	N/A	0.013%
10/24/2024	Wealth Enhancement Advisory Services LLC	45,273	$90K	0.0%	+21.2%	0.030%
10/22/2024	Searle & CO.	86,250	$0.17M	0.0%	+684.1%	0.057%
10/16/2024	Firethorn Wealth Partners LLC	26,013	$52K	0.0%	N/A	0.017%
10/9/2024	Congress Park Capital LLC	1,978,078	$3.94M	1.5%	+25.3%	1.313%
10/3/2024	SG Americas Securities LLC	70,917	$0.14M	0.0%	-64.2%	0.047%
8/19/2024	B. Riley Wealth Advisors Inc.	11,602	$41K	0.0%	N/A	0.008%
8/16/2024	Clearline Capital LP	1,495,266	$5.23M	0.1%	-46.1%	0.993%
8/15/2024	The Manufacturers Life Insurance Company	45,771	$0.16M	0.0%	+16.0%	0.030%
8/15/2024	Millennium Management LLC	1,434,627	$5.02M	0.0%	-54.7%	0.952%
8/15/2024	AQR Capital Management LLC	607,135	$2.13M	0.0%	+1,460.9%	0.403%
8/15/2024	Caxton Associates LP	202,157	$0.71M	0.0%	N/A	0.134%
8/14/2024	Squarepoint Ops LLC	363,700	$1.27M	0.0%	+369.0%	0.241%
8/14/2024	Marshall Wace LLP	1,761,051	$6.16M	0.0%	+256.2%	1.169%
8/14/2024	Profund Advisors LLC	48,073	$0.17M	0.0%	N/A	0.032%
8/13/2024	Sei Investments Co.	12,685	$44K	0.0%	N/A	0.008%
8/13/2024	Orchard Capital Management LLC	2,243,426	$7.85M	2.4%	-1.3%	1.489%
8/12/2024	Richmond Brothers Inc.	356,558	$1.25M	2.5%	+20.2%	0.237%
8/12/2024	XTX Topco Ltd	54,205	$0.19M	0.0%	-74.0%	0.036%
8/12/2024	E Fund Management Co. Ltd.	15,642	$55K	0.0%	N/A	0.010%
8/10/2024	Wealth Alliance	32,000	$0.11M	0.0%	+60.0%	0.021%
8/9/2024	Pekin Hardy Strauss Inc.	25,170	$88K	0.0%	-19.2%	0.017%
8/9/2024	Renaissance Technologies LLC	1,993,800	$6.98M	0.0%	-17.1%	1.323%
8/7/2024	Headlands Technologies LLC	90,495	$0.32M	0.0%	+731.3%	0.060%
8/7/2024	Monaco Asset Management SAM	1,513,164	$5.30M	0.8%	-16.5%	1.004%
8/6/2024	Acadian Asset Management LLC	36,462	$0.13M	0.0%	N/A	0.024%
8/6/2024	Los Angeles Capital Management LLC	238,899	$0.84M	0.0%	-51.6%	0.159%
8/1/2024	Rhumbline Advisers	184,472	$0.65M	0.0%	+31.5%	0.122%
7/31/2024	nVerses Capital LLC	7,800	$27K	0.0%	N/A	0.005%
7/30/2024	Searle & CO.	11,000	$38K	0.0%	-87.2%	0.007%
7/29/2024	Principal Financial Group Inc.	18,446	$65K	0.0%	-49.0%	0.012%
7/29/2024	Panagora Asset Management Inc.	562,228	$1.97M	0.0%	+49.8%	0.373%
7/27/2024	HB Wealth Management LLC	10,000	$35K	0.0%	N/A	0.007%
7/26/2024	Legato Capital Management LLC	239,239	$0.84M	0.1%	N/A	0.159%
7/26/2024	Bank of New York Mellon Corp	449,212	$1.57M	0.0%	+33.9%	0.298%
7/24/2024	Zweig DiMenna Associates LLC	128,592	$0.45M	0.1%	-59.8%	0.085%
7/22/2024	Capital Investment Counsel Inc	14,625	$51K	0.0%	+27.2%	0.010%
7/17/2024	Baader Bank Aktiengesellschaft	36,128	$0.13M	0.0%	N/A	0.024%
7/16/2024	Apeiron RIA LLC	188,635	$0.66M	0.2%	+52.1%	0.125%
7/12/2024	Congress Park Capital LLC	1,578,501	$5.53M	2.2%	-4.0%	1.048%
7/12/2024	SG Americas Securities LLC	198,186	$0.69M	0.0%	N/A	0.132%
7/10/2024	Valeo Financial Advisors LLC	12,747	$45K	0.0%	N/A	0.008%
5/16/2024	California State Teachers Retirement System	10,409	$29K	0.0%	-38.9%	0.007%
5/15/2024	Price T Rowe Associates Inc. MD	29,922	$83K	0.0%	+15.4%	0.020%
5/14/2024	CM Management LLC	300,000	$0.83M	0.7%	-7.7%	0.199%
5/10/2024	Vanguard Group Inc.	8,114,716	$22.48M	0.0%	-2.7%	5.387%
5/9/2024	Monaco Asset Management SAM	1,813,164	$5.02M	1.5%	-18.6%	1.204%
5/9/2024	State Board of Administration of Florida Retirement System	40,705	$0.11M	0.0%	+51.4%	0.027%
5/8/2024	Headlands Technologies LLC	10,886	$30K	0.0%	N/A	0.007%
5/7/2024	Susquehanna Fundamental Investments LLC	11,727	$32K	0.0%	N/A	0.008%
5/3/2024	GSA Capital Partners LLP	279,699	$0.78M	0.1%	-17.6%	0.186%
5/1/2024	BNP Paribas Financial Markets	51,296	$0.14M	0.0%	+80.7%	0.034%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	32,615	$90K	0.0%	N/A	0.022%
4/30/2024	Commonwealth Equity Services LLC	338,526	$0.94M	0.0%	+3.1%	0.225%
4/18/2024	Diversified Trust Co	23,966	$66K	0.0%	N/A	0.016%
4/16/2024	Congress Park Capital LLC	1,644,785	$4.56M	2.0%	-8.6%	1.094%
4/5/2024	Los Angeles Capital Management LLC	493,264	$1.37M	0.0%	-4.1%	0.328%
2/15/2024	Orchard Capital Management LLC	2,243,426	$3.81M	1.2%	+4.7%	1.495%
2/9/2024	JW Asset Management LLC	2,292,418	$3.90M	2.2%	-4.8%	1.528%
2/9/2024	Franklin Resources Inc.	6,404,795	$10.89M	0.0%	-8.0%	4.268%
2/9/2024	D.A. Davidson & CO.	30,100	$51K	0.0%	-25.9%	0.020%
2/8/2024	Richmond Brothers Inc.	296,706	$0.50M	0.9%	+188.0%	0.198%
2/8/2024	Panagora Asset Management Inc.	139,113	$0.24M	0.0%	N/A	0.093%
2/7/2024	Monaco Asset Management SAM	2,226,475	$3.79M	1.1%	+219.5%	1.484%
2/6/2024	Los Angeles Capital Management LLC	514,377	$0.87M	0.0%	+49.9%	0.343%
2/5/2024	Victory Capital Management Inc.	19,929	$34K	0.0%	+30.2%	0.013%
2/5/2024	Pekin Hardy Strauss Inc.	36,470	$62K	0.0%	-38.3%	0.024%
1/31/2024	Knights of Columbus Asset Advisors LLC	83,482	$0.14M	0.0%	+100.0%	0.056%
1/30/2024	ACT Advisors LLC.	22,145	$38K	0.0%	N/A	0.015%
1/19/2024	Congress Park Capital LLC	1,798,650	$3.06M	1.5%	+205.3%	1.199%
1/16/2024	Raymond James Financial Services Advisors Inc.	48,309	$82K	0.0%	+61.2%	0.032%
11/15/2023	Tejara Capital Ltd	2,109,681	$2.17M	1.2%	+28.6%	1.499%
11/15/2023	Rubric Capital Management LP	26,713,503	$27.52M	1.0%	+127.3%	18.978%
11/15/2023	Adage Capital Partners GP L.L.C.	2,000,000	$2.06M	0.0%	+100.0%	1.421%
11/13/2023	Tejara Capital Ltd	2,109,681	$2.17M	1.6%	+28.6%	1.499%
11/9/2023	JW Asset Management LLC	2,407,418	$2.48M	1.1%	+9.1%	1.710%
11/8/2023	D.A. Davidson & CO.	40,600	$42K	0.0%	-84.2%	0.029%
11/8/2023	Pekin Hardy Strauss Inc.	59,095	$61K	0.0%	-44.3%	0.042%
11/7/2023	Monaco Asset Management SAM	696,908	$0.72M	0.2%	+72.1%	0.495%
11/7/2023	CM Management LLC	450,000	$0.46M	0.5%	-10.0%	0.320%
11/7/2023	New York State Common Retirement Fund	1,094,441	$1.13M	0.0%	-1.5%	0.778%
11/3/2023	Richmond Brothers Inc.	103,009	$0.11M	0.2%	+142.9%	0.073%
11/1/2023	Jacob Asset Management of New York LLC	327,450	$0.34M	0.5%	+18.2%	0.233%
10/27/2023	Allspring Global Investments Holdings LLC	41,034	$42K	0.0%	-30.4%	0.029%
10/24/2023	Bank of New York Mellon Corp	353,395	$0.36M	0.0%	+5.8%	0.251%
10/24/2023	Dakota Wealth Management	53,315	$55K	0.0%	N/A	0.038%
10/23/2023	Commonwealth Equity Services LLC	314,826	$0.32M	0.0%	+5.5%	0.224%
10/19/2023	Apeiron RIA LLC	83,000	$85K	0.0%	+59.6%	0.059%
10/13/2023	SG Americas Securities LLC	30,560	$31K	0.0%	N/A	0.022%
10/13/2023	Congress Park Capital LLC	589,150	$0.61M	0.3%	+15.2%	0.419%
9/21/2023	Barclays PLC	57,233	$65K	0.0%	-42.1%	0.041%
8/14/2023	X Square Capital LLC	31,185	$36K	0.0%	-78.9%	0.026%
8/14/2023	ArrowMark Colorado Holdings LLC	26,373	$31K	0.0%	-99.2%	0.022%
8/14/2023	Great Point Partners LLC	4,737,368	$5.50M	1.1%	-18.6%	3.957%
8/14/2023	Jefferies Financial Group Inc.	1,290,924	$1.50M	0.0%	N/A	1.078%
8/14/2023	Deep Track Capital LP	2,086,704	$2.42M	0.1%	-35.5%	1.482%
8/14/2023	Palisade Capital Management LP	4,143,649	$4.81M	0.1%	+4.4%	3.461%
8/14/2023	Graham Capital Management L.P.	169,148	$0.20M	0.0%	+576.4%	0.141%

Data available starting January 2016

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.

Today's Range

Now: $1.78

$1.75

$1.85

50 Day Range

MA: $1.88

$1.73

$2.12

52 Week Range

Now: $1.78

$0.50

$3.93

Volume

1,004,738 shs

Average Volume

2,405,979 shs

Market Capitalization

$269.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.81

Who are the company insiders with the largest holdings of Heron Therapeutics?: Heron Therapeutics' top insider shareholders include:
Adam Morgan (Director)
Craig A Collard (CEO)
Ira Duarte (CFO)
William P Forbes (EVP)
Learn More about top insider investors at Heron Therapeutics.
Who are the major institutional investors of Heron Therapeutics?: Heron Therapeutics' top institutional shareholders include:
Congress Park Capital LLC — 1.31%
Los Angeles Capital Management LLC — 0.15%
Principal Financial Group Inc. — 0.07%
Searle & CO. — 0.06%
SG Americas Securities LLC — 0.05%
Wealth Enhancement Advisory Services LLC — 0.03%
Learn More about top institutional investors of Heron Therapeutics stock.
Which institutional investors are selling Heron Therapeutics stock?: Within the last quarter, HRTX stock was sold by these institutional investors:
SG Americas Securities LLC
Los Angeles Capital Management LLC
Which institutional investors are buying Heron Therapeutics stock?: In the previous quarter, HRTX stock was bought by institutional investors including:
Congress Park Capital LLC
Principal Financial Group Inc.
Searle & CO.
Firethorn Wealth Partners LLC
Cutter & CO Brokerage Inc.
Wealth Enhancement Advisory Services LLC
Within the last year, these company insiders have bought Heron Therapeutics stock:
Adam Morgan (Director)
Craig A Collard (CEO)
Ira Duarte (CFO)
William P Forbes (EVP)
Learn More investors buying Heron Therapeutics stock.